The mission of Project ECHO® (Extension for Community Healthcare Outcomes) is to develop the capacity to safely and effectively treat chronic, common, and complex diseases in rural and underserved areas, and to monitor outcomes of this treatment.
Project ECHO® is funded in part by a grant from the Robert Wood Johnson Foundation and has received support from the New Mexico Legislature, the University of New Mexico, and the New Mexico Department of Public Health.
IT: (505) 750-4897
Fax: (505) 272-6906
Project ECHO® has been awarded nearly $8.5 million over three years from the U.S. Department of Health and Human Services (HHS) Health Care Innovation awards. UNM will identify 5,000 high-cost, high-utilization, high-severity patients in New Mexico and Washington State, and use a team of primary care “intensivists” trained to care for complex patients with multiple chronic diseases, working with area managed care organizations and care providers. Read more.
Project ECHO® is sponsoring a NO-cost training in the use of buprenorphine (Suboxone®) to treat opioid addiction in an office-based setting. Buprenorphine is a highly effective medication that can be used to support recovery from addiction to pain pills, heroin, and other opioid drugs. This training meets the federal requirements for physicians who wish to obtain certification to prescribe buprenorphine.
The training will be held on Saturday, April 13, 2013, 8:00 am-3:30 pm at the Rotunda Conference Room, UNM Science & Technology Park, 801 University Blvd. SE (east side of building), Albuquerque.
To register go to Register.
***Registrants will be required to complete a DVD-based training at home prior to the face-to-face training.
This training is recommended for physicians; especially those working in addiction medicine, primary care, pain management, psychiatry and HIV. Other health care team members (non-physicians) are also invited to participate, but are not eligible to obtain the waiver to prescribe buprenorphine due to restrictions in federal law.
The objectives of the training will be to introduce and train health care practitioners in the use of buprenorphine, an office-based medical treatment option for opiate addiction. Physicians will then complete the certification process for buprenorphine prescriptive privilege.
All registrants will receive an information packet in the mail, including a DVD that contains training on substance abuse treatments, opioids and the use of buprenorphine in the treatment of opioid use disorders. Registrants must agree to complete this training prior to the face-to-face, classroom-style training on Saturday, April 13th.
For questions please contact Melissa Meier at (505) 272-5811 or email@example.com
There is now only one toll-free number for each and every ECHO Clinic! (Individual clinic PIN numbers, however, remain the same.)
For pediatric telemedicine, including asthma care, please contact Envision New Mexico.